These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 9105085
21. Functional properties of guinea pig eosinophil leukotriene B4 receptor. Ng CF, Sun FF, Taylor BM, Wolin MS, Wong PY. J Immunol; 1991 Nov 01; 147(9):3096-103. PubMed ID: 1655904 [Abstract] [Full Text] [Related]
22. Human monocyte and polymorphonuclear leukocyte chemotactic and chemokinetic responses to leukotriene B4 and FMLP. Ternowitz T, Herlin T, Fogh K. Acta Pathol Microbiol Immunol Scand C; 1987 Apr 01; 95(2):47-54. PubMed ID: 3037849 [Abstract] [Full Text] [Related]
23. A formyl peptide contracts guinea pig lung: role of arachidonic acid metabolites. Shore SA, Stimler-Gerard NP, Smith E, Drazen JM. J Appl Physiol (1985); 1987 Dec 01; 63(6):2450-9. PubMed ID: 2893781 [Abstract] [Full Text] [Related]
24. Eosinophil infiltration and enhancement of airway reactivity by leukocyte chemotactic factor, formyl-methionyl-leucyl-phenylalanine (fMLP), in guinea pigs. Amagai M, Ohashi Y, Makino S. Arerugi; 1992 Nov 01; 41(11):1547-60. PubMed ID: 1492788 [Abstract] [Full Text] [Related]
25. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions. Tsai BS, Villani-Price D, Keith RH, Zemaitis JM, Bauer RF, Leonard R, Djuric SW, Shone RL. Prostaglandins; 1989 Dec 01; 38(6):655-74. PubMed ID: 2561214 [Abstract] [Full Text] [Related]
27. Effects of leukotrienes B4 (LTB4) and D4 (LTD4) on motility of isolated normodense human eosinophils and neutrophils. Spada CS, Krauss AH, Nieves AL, Woodward DF. Adv Exp Med Biol; 1997 Apr 06; 400B():699-706. PubMed ID: 9547621 [Abstract] [Full Text] [Related]
28. Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4. Munoz NM, Vita AJ, Neeley SP, McAllister K, Spaethe SM, White SR, Leff AR. J Pharmacol Exp Ther; 1994 Jan 06; 268(1):139-43. PubMed ID: 8301549 [Abstract] [Full Text] [Related]
29. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator. Erger RA, Casale TB. Am J Respir Cell Mol Biol; 1995 Jan 06; 12(1):65-70. PubMed ID: 7811471 [Abstract] [Full Text] [Related]
30. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions. Kishikawa K, Tateishi N, Maruyama T, Seo R, Toda M, Miyamoto T. Prostaglandins; 1992 Oct 06; 44(4):261-75. PubMed ID: 1332129 [Abstract] [Full Text] [Related]
31. Participation of interleukin-5 and interleukin-8 in the eosinophil migration induced by a large volume of saline. Oliveira SH, Faccioli LH, Cunha FQ, Ferreira SH. Int Arch Allergy Immunol; 1996 Nov 06; 111(3):244-52. PubMed ID: 8917119 [Abstract] [Full Text] [Related]
32. Generation of leukotrienes by human monocytes pretreated with cytochalasin B and stimulated with formyl-methionyl-leucyl-phenylalanine. Williams JD, Robin JL, Lewis RA, Lee TH, Austen KF. J Immunol; 1986 Jan 06; 136(2):642-8. PubMed ID: 3001181 [Abstract] [Full Text] [Related]
33. Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy. Vaananen PM, Keenan CM, Grisham MB, Wallace JL. Inflammation; 1992 Jun 06; 16(3):227-40. PubMed ID: 1323529 [Abstract] [Full Text] [Related]
34. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. Morita E, Schröder JM, Christophers E. Scand J Immunol; 1989 Jun 06; 29(6):709-16. PubMed ID: 2544988 [Abstract] [Full Text] [Related]
35. Effect of leukotriene B4 on enhancement of superoxide production evoked by formyl-methionyl-leucyl-phenylalanine in myeloid differentiated HL-60 cells: possible involvement of intracellular calcium influx and high affinity receptor for leukotriene B4. Harada Y. Hiroshima J Med Sci; 1990 Sep 06; 39(3):89-94. PubMed ID: 2178158 [Abstract] [Full Text] [Related]
36. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists. Coëffier E, Joseph D, Vargaftig BB. J Immunol; 1991 Oct 15; 147(8):2595-602. PubMed ID: 1655895 [Abstract] [Full Text] [Related]
37. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro. Nabe T, Yamamura H, Kohno S. Arzneimittelforschung; 1997 Oct 15; 47(10):1112-6. PubMed ID: 9368704 [Abstract] [Full Text] [Related]
38. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Underwood DC, Osborn RR, Newsholme SJ, Torphy TJ, Hay DW. Am J Respir Crit Care Med; 1996 Oct 15; 154(4 Pt 1):850-7. PubMed ID: 8887574 [Abstract] [Full Text] [Related]
39. Selective localization of recognition complexes for leukotriene B4 and formyl-Met-Leu-Phe within lipid raft microdomains of human polymorphonuclear neutrophils. Sitrin RG, Emery SL, Sassanella TM, Blackwood RA, Petty HR. J Immunol; 2006 Dec 01; 177(11):8177-84. PubMed ID: 17114494 [Abstract] [Full Text] [Related]
40. The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole blood assay. Brideau C, Van Staden C, Styhler A, Rodger IW, Chan CC. Br J Pharmacol; 1999 Feb 01; 126(4):979-88. PubMed ID: 10193778 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]